Home » Topics » BioWorld Science

BioWorld Science
RSS

Ultrarare variants give insights into schizophrenia

March 29, 2021

Cholesterol-independent heart disease risk gene

March 29, 2021

Phase I study of intranasal adenovirus vector COVID-19 vaccine candidate, BBV-154

March 29, 2021

Albireo initiates dosing in key clinical studies with two of its candidates

March 29, 2021

PepGen develops enhanced delivery oligonucleotides for muscular dystrophy

March 29, 2021

Anaveon gains CTA clearance for phase I/II study of ANV-419 in advanced solid tumors

March 26, 2021

Chinese phase III trial of LY-03005 for major depressive disorder meets endpoints

March 26, 2021

FDA accepts IND for phase Ib study of AT-100 for bronchopulmonary dysplasia

March 26, 2021

Sorrento reports further phase Ib data on COVI-MSC for COVID-19-induced ARDS

March 26, 2021

First-in-human data presented for SRP-9003 in patients with limb girdle muscular dystrophy type 2E

March 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...